Broadcom Falls on Q4 Earnings: Tilray Up on Marijuana Reclassification Potential | Stock Movers
December 12, 2025
421
11
6
4.04%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Podcasts Episodes Around December 12, 2025
See what was published immediately before and after this episode.
3:40Now PlayingBroadcom Falls on Q4 Earnings: Tilray Up on Marijuana Reclassification Potential | Stock Movers
YouTube Description
as posted by the channelOn this episode of Stock Movers with Lisa Mateo:
- Shares of Broadcom (AVGO) tumbled in premarket trading after its sales outlook for the red-hot market failed to meet investors’ lofty expectations. The shares fell about 5% in premarket trading on Friday, following unsettling commentary from Chief Executive Officer Hock Tan on a conference call with analysts. He said the company has a backlog of $73 billion in AI product orders that will be shipped over the next six quarters — a number that disappointed some investors. But Tan sought to clarify that the figure was a “minimum.”
- Shares of Lululemon Athletica (LULU) rallied ahead of the US market open after the athleisure purveyor boosted its full-year earnings-per-share guidance, called early holiday performance encouraging, and announced a $1 billion increase to its stock buyback program. Lululemon’s fiscal third-quarter report had several positive nuggets for investors after a tough year. Profit and comparable sales beat analyst expectations in the quarter, driven by growth in international markets. Revenue in the US slipped 3% on a constant-currency basis. The company is also searching for a replacement for CEO Calvin McDonald, who will depart the top post at the end of January.
- Shares of Tilray (TLRY) and other cannabis brands soared in the early trading session as President Trump is expected to direct his administration to move to reclassify marijuana as a less dangerous drug, according to people familiar with the matter, a move that could represent one of the biggest shifts in US policy toward cannabis in decades. Trump has discussed the idea with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare & Medicaid Services Administrator Mehmet Oz, the people said. A White House official said no final decisions have been made on rescheduling.
--------
Watch Bloomberg Radio LIVE on YouTube
Weekdays 7am-6pm ET
Follow us on X
Subscribe to our Podcasts:
Bloomberg Daybreak
Bloomberg Surveillance
Bloomberg Intelligence
Balance of Power
Bloomberg Businessweek
Listen on Apple CarPlay and Android Auto with the Bloomberg Business app:
Apple CarPlay
Android Auto
Visit our YouTube channels:
Bloomberg Podcasts
Bloomberg Television
Bloomberg Originals
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.